This inventor holds 7 USPTO granted patents and 25 published patent applications and 1 EPO patent. Top assignee: Cipla Limited. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mumbai, IN (2016 - 2019)
- Maharashtra, IN (2017 - 2021)
Company Filing History:
Years Active: 2016-2025
Title: Shrinivas Madhukar Purandare: Innovator in Pharmaceutical Compositions
Introduction
Shrinivas Madhukar Purandare is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work primarily focuses on developing innovative pharmaceutical compositions that enhance treatment options for various medical conditions.
Latest Patents
Among his latest patents, Purandare has developed a pharmaceutical composition for inhalation that includes R (+) budesonide along with one or more bronchodilators. This composition may also contain one or more pharmaceutically acceptable excipients. Additionally, he has created a pharmaceutical antiretroviral composition that comprises at least one integrase inhibitor or its derivatives, combined with at least one antiretroviral or anti-HIV agent. These advancements reflect his commitment to improving therapeutic efficacy in the pharmaceutical industry.
Career Highlights
Purandare is currently associated with Cipla Limited, a leading global pharmaceutical company. His role at Cipla has allowed him to contribute to the development of innovative healthcare solutions. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.
Collaborations
Throughout his career, Purandare has collaborated with talented professionals, including Geena Malhotra and Amar Lulla. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical innovations.
Conclusion
Shrinivas Madhukar Purandare's contributions to pharmaceutical compositions demonstrate his dedication to advancing medical science. His innovative patents and collaborations highlight his significant impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
